Go Pro

UpHealth (UPHL) 10K Form and Latest SEC Filings 2026

$0.0001 0.00 (0.00%)
As of 09/8/2026 12:10 PM Eastern

Latest UpHealth SEC Filings & Recent Activity

UpHealth (NYSE:UPHL) has submitted 327+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form NT 10-K submitted on March 31, 2025.

DateFilerForm TypeView
03/31/2025 3:01 PM
UpHealth (1770141) Filer
Form NT 10-K
09/27/2024 3:10 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024 7:32 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024 4:21 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024 1:43 PM
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
UpHealth (1770141) Subject
Form 25-NSE
06/07/2024 6:34 PM
REY-GIRAUD AGNES (1235685) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024 6:36 PM
Beck Martin S A (1866167) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024 6:37 PM
Jennings Jay Walter (1685730) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024 7:01 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024 7:03 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024 8:17 PM
UpHealth (1770141) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024 8:39 PM
UpHealth (1770141) Filer
Form NT 10-K
04/01/2024 7:27 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024 3:34 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024 4:14 PM
UpHealth (1770141) Filer
Form 424B3
03/20/2024 3:38 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024 7:30 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024 8:57 PM
UpHealth (1770141) Filer
Form 424B3
02/20/2024 3:20 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024 3:44 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024 3:48 PM
UpHealth (1770141) Filer
Form DEFA14A
02/15/2024 3:29 PM
Beck Martin S A (1866167) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:20 PM
GREENE JAMES S (1116229) Reporting
UpHealth (1770141) Issuer
Form 3
Initial statement of beneficial ownership of securities  
02/02/2024 5:21 PM
Katz Avi S (1451693) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:21 PM
Pylypiv Mariya (1865982) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:21 PM
Dinu Raluca (1430575) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:22 PM
GUINAN MARK (1505998) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:22 PM
MACHUCA LUIS (1133099) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:23 PM
REY-GIRAUD AGNES (1235685) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:23 PM
KATHURIA CHIRINJEEV (1163768) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:23 PM
GREENE JAMES S (1116229) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024 5:24 PM
Locke Nathan (1864751) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024 5:06 AM
UpHealth (1770141) Filer
Form DEFM14A
01/10/2024 4:23 PM
UpHealth (1770141) Filer
Form PREM14A
12/28/2023 5:30 AM
UpHealth (1770141) Filer
Form 424B3
12/27/2023 4:13 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023 5:32 AM
UpHealth (1770141) Filer
Form 424B3
12/13/2023 3:24 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023 8:46 AM
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
UpHealth (1770141) Subject
Form 25-NSE
11/29/2023 3:15 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023 7:20 PM
Dinu Raluca (1430575) Filed by
UpHealth (1770141) Subject
Form SC 13D
Major Buy Alert Issued for September 30th (Ad)

Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of September 30th. See which stocks his AI research platform is flagging right now.tc pixel

See which stocks his AI research platform is flagging now
11/27/2023 7:21 PM
REY-GIRAUD AGNES (1235685) Filed by
UpHealth (1770141) Subject
Form SC 13D
11/27/2023 7:22 PM
MACHUCA LUIS (1133099) Filed by
UpHealth (1770141) Subject
Form SC 13D
11/27/2023 7:23 PM
Locke Nathan (1864751) Filed by
UpHealth (1770141) Subject
Form SC 13D
11/27/2023 7:24 PM
GUINAN MARK (1505998) Filed by
UpHealth (1770141) Subject
Form SC 13D
11/27/2023 7:25 PM
Jennings Jay Walter (1685730) Filed by
UpHealth (1770141) Subject
Form SC 13D
11/27/2023 7:28 PM
Katz Avi S (1451693) Filed by
UpHealth (1770141) Subject
Form SC 13D
11/27/2023 7:29 PM
Beck Martin S A (1866167) Filed by
UpHealth (1770141) Subject
Form SC 13D
11/27/2023 7:34 PM
KATHURIA CHIRINJEEV (1163768) Filed by
UpHealth (1770141) Subject
Form SC 13D/A
11/27/2023 4:29 PM
UpHealth (1770141) Subject
Form SC 13D
11/22/2023 5:59 PM
Katz Avi S (1451693) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023 5:30 AM
UpHealth (1770141) Filer
Form 424B3
11/20/2023 4:24 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023 4:25 PM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023 4:28 PM
UpHealth (1770141) Filer
Form DEFA14A
10/20/2023 10:16 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023 4:59 PM
Jennings Jay Walter (1685730) Reporting
UpHealth (1770141) Issuer
Form 3
Initial statement of beneficial ownership of securities  
10/11/2023 3:23 PM
Beck Martin S A (1866167) Reporting
UpHealth (1770141) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023 7:30 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023 8:13 PM
Riva Ridge Capital Management LP (1676700) Filed by
UpHealth (1770141) Subject
Form SC 13D
09/26/2023 3:43 PM
Lynrock Lake LP (1734341) Filed by
UpHealth (1770141) Subject
Form SC 13D
09/19/2023 7:01 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023 8:00 AM
UpHealth (1770141) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

UpHealth SEC Filings - Frequently Asked Questions

UpHealth (UPHL) has submitted 327+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

UpHealth's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form NT 10-K submitted on March 31, 2025. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NYSE:UPHL are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 3/31/2025. New filings are added as they're published.
From Our Partners